Skip to content

GER Poses a Potential Risk for Late Complications of BPD

Gastroesophageal Reflux Poses a Potential Risk for Late Complications of BPD: A Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03014453
Enrollment
187
Registered
2017-01-09
Start date
2017-01-09
Completion date
2018-07-22
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia, Gastroesophageal Reflux

Brief summary

Bronchopulmonary dysplasia (BPD) is a common condition in the low birth weight infants. Although most of the BPD symptoms improved after a regular treatment in infancy, there are still a few late complications left such as the frequent respiratory symptoms, a slower weight gain and even sudden death. These late complications have made so much trouble to the healthcare of BPD infants. How to find the risk factors and to reduce the prevalence of these late symptoms becomes necessary. In this study, a cohort of BPD infants was observed with the late complications obtained by a monthly followed up for 18 months after discharge, the prevalence and risk factors of the late complications of BPD were analyzed by logistic regression. As one of the risk factors, GER was verified whether to play a critical role in these late complications.

Interventions

None listed

Sponsors

Shengjing Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 32 Weeks
Healthy volunteers
No

Inclusion criteria

* the extremely premature infants with bronchopulmonary dysplasia

Exclusion criteria

* other congenital malformations such as gastrointestinal and or neurogenic disease

Design outcomes

Primary

MeasureTime frameDescription
the Late Complications of BPD Infants18 monthsIn all patients, complications were evaluated via questionnaires at 3, 6, 9 and 12 months corrected for premature age, including respiratory symptoms (including home respiratory support, respiratory medication administration, cough without cold at least once per week, re-hospitalization due to respiratory diseases), vomiting when feeding, hypoxic ischemic injury, retinopathy of prematurity, rehospitalization and sudden death.

Countries

China

Participant flow

Recruitment details

The cohort study was conducted with BPD infants born≤32 weeks gestational age (GA) between January 2017 and July 2018 at Shengjing Hospital of China Medical University.The BPD was diagnosed at 36 weeks postmenstrual age (PMA) on the National Heart, Lung and Blood Institute classification and categorized as mild, moderate or severe.

Participants by arm

ArmCount
Extremely Premature Infants With Bronchopulmonary Dysplasia
This observational cohort study was conducted with BPD infants born≤32 weeks gestational age (GA) at Shengjing Hospital of China Medical University neonatal intensive care unit (NICU). None of them received antacid medications, inhaled medications, or diuretics.
116
Total116

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDiscontinued GER3
Overall StudyExcluded19
Overall StudyLost to Follow-up12
Overall StudyRefused to take part in37

Baseline characteristics

CharacteristicExtremely Premature Infants With Bronchopulmonary Dysplasia
1min Apgar
1 min Apgar>=7
89 Participants
1min Apgar
1min Apgar<7
27 Participants
Age, Customized
gestational age<30 week
51 participants
Age, Customized
gestational age>=30 week
65 participants
Application of caffeine
no
37 Participants
Application of caffeine
yes
79 Participants
Application of pulmonary surfactant
no
40 Participants
Application of pulmonary surfactant
yes
76 Participants
birth weight
<1500g
71 Participants
birth weight
>1500g
45 Participants
Gastroesophageal reflux
Acid GER
21 Participants
Gastroesophageal reflux
DGER
28 Participants
Gastroesophageal reflux
No
67 Participants
Invasive ventilation
Invasive ventilation<7 days
88 Participants
Invasive ventilation
Invasive ventilation>=7 days
28 Participants
patent ductus arteriosus
no
87 Participants
patent ductus arteriosus
yes
29 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
44 Participants
Sex: Female, Male
Male
72 Participants
Ventilator-associated Pneumonia
no
61 Participants
Ventilator-associated Pneumonia
yes
55 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 116
other
Total, other adverse events
69 / 116
serious
Total, serious adverse events
64 / 116

Outcome results

Primary

the Late Complications of BPD Infants

In all patients, complications were evaluated via questionnaires at 3, 6, 9 and 12 months corrected for premature age, including respiratory symptoms (including home respiratory support, respiratory medication administration, cough without cold at least once per week, re-hospitalization due to respiratory diseases), vomiting when feeding, hypoxic ischemic injury, retinopathy of prematurity, rehospitalization and sudden death.

Time frame: 18 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Extremely Premature Infants With Bronchopulmonary Dysplasiathe Late Complications of BPD Infantsrespiratory symptoms57 Participants
Extremely Premature Infants With Bronchopulmonary Dysplasiathe Late Complications of BPD InfantsVomiting when feeding45 Participants
Extremely Premature Infants With Bronchopulmonary Dysplasiathe Late Complications of BPD Infantsretinopathy of prematurity30 Participants
Extremely Premature Infants With Bronchopulmonary Dysplasiathe Late Complications of BPD Infantshypoxic ischemic injury4 Participants
Extremely Premature Infants With Bronchopulmonary Dysplasiathe Late Complications of BPD Infantssudden infant death syndrome1 Participants
Extremely Premature Infants With Bronchopulmonary Dysplasiathe Late Complications of BPD Infantsrehospitalization31 Participants

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026